NORWOOD, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief…
January 06, 2025
January 04, 2025
Why Viking Therapeutics Stock Plummeted by 24% in December
Viking Therapeutics (NASDAQ: VKTX) didn’t exactly capture investors’ hearts in the final month of 2024. In mid-December, Merck announced it had entered into a licensing…
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness…
January 03, 2025
From Davids to Goliaths: the GLP-1R gold rush
There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.